Your browser doesn't support javascript.
Which patients bring the most costs for hospital? A study on the cost determinants among COVID-19 patients in Iran.
Ramezani-Doroh, Vajihe; Tapak, Leili; Hamidi, Yadollah; Bashirian, Saeid; Soltanian, Ali Reza; Motaghed, Mahyar; Ghelichkhani, Ebrahim; Talebi-Ghane, Elaheh.
  • Ramezani-Doroh V; Department of Health Management and Economics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Tapak L; Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, PO Box: 65176-19657, Hamadan, Iran.
  • Hamidi Y; Department of Biostatistics, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Bashirian S; Department of Health Management and Economics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Soltanian AR; Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Motaghed M; Department of Biostatistics, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Ghelichkhani E; Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Talebi-Ghane E; Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
Cost Eff Resour Alloc ; 20(1): 52, 2022 Sep 24.
Article in English | MEDLINE | ID: covidwho-2043131
ABSTRACT

BACKGROUND:

Accurate information on the cost determinants in the COVID-19 patients could provide policymakers a valuable planning tool for dealing with the future COVID-19 crises especially in the health systems with limited resources.

OBJECTIVES:

This study aimed to determine the factors affecting direct medical cost of COVID-19 patients in Hamadan, the west of Iran.

METHODS:

This study considered 909 confirmed COVID-19 patients with positive real-time reverse-transcriptase polymerase-chain-reaction test which were hospitalized from 1 March to 31 January 2021 in Farshchian (Sina) hospital in Hamadan, Iran. A checklist was utilized to assess the relationship of demographic characteristics, clinical presentation, medical laboratory findings and the length of hospitalization to the direct hospitalization costs in two groups of patients (patients with hospitalization ≤ 9 days and > 9 days). Statistical analysis was performed using chi-square, median test and multivariable quantile regression model at 0.05 significance levels with Stata 14 software program.

RESULTS:

The median cost of hospitalization in patients was totally 134.48 dollars (Range 19.19-2397.54) and respectively 95.87 (Range 19.19-856.63) and 507.30 dollars (Range 68.94-2397.54) in patients with hospitalization ≤ 9 days and > 9 days. The adjusted estimates presented that in patients with 9 or less hospitalization days history of cardiovascular disease, wheezing pulmonary lung, SPO2 lower than 90%, positive CRP, LDH higher than 942 U/L, NA lower than 136 mEq/L, lymphosite lower than 20% and patients with ICU experience had significantly positive relationship to the median of cost. Moreover, in patients with more than 9 hospitalization days, history of cardiovascular disease and ICU experience was statistically positive association and age older than 60 years and WBC lower than 4.5 mg/dL had statistically negative relationship to the median of hospitalization cost.

CONCLUSION:

As the length of hospital stay, which can be associated with the severity of the disease, increases, health systems become more vulnerable in terms of resource utilization, which in turn can challenge their responsiveness and readiness to meet the specialized treatment needs of individuals.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Cost Eff Resour Alloc Year: 2022 Document Type: Article Affiliation country: S12962-022-00386-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Cost Eff Resour Alloc Year: 2022 Document Type: Article Affiliation country: S12962-022-00386-9